US Patent Issued to Miltenyi Biotec on June 3 for "Reducing side effects of immunotherapy using genetically modified hematopoietic cells" (German Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,446, issued on June 3, was assigned to Miltenyi Biotec B.V. & Co. Kg (Bergisch Gladbach, Germany).

"Reducing side effects of immunotherapy using genetically modified hematopoietic cells" was invented by Michael Lutteropp (Bergisch Gladbach, Germany), Anne Richter (Bergisch Gladbach, Germany), Andrew Kaiser (Bergisch Gladbach, Germany), Mario Assenmacher (Bergisch Gladbach, Germany) and Stefan Miltenyi (Bergisch Gladbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a system for preventing or reducing side effects in a patent undergoing immunotherapy to remove diseased cells that express a target antigen: for example...